The advent of single-cell omics technologies has revolutionized our understanding of the complex cellular landscape in cancer. Traditional bulk sequencing ...

Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc. ("Takara Bio"), today announced data from a benchmark ...

Understanding which cells within a tumor will go on to form metastases remains one of the major challenges in cancer research ...

This work, published in Nature Communications, opens new avenues for identifying tumors with a high risk of developing ...